We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Not there yet

17 January 2007 By Robert Cyran

The drugstore chain has sweetened its contested $23bn bid for benefits manager Caremark and promised to lever up the combined company. Yet Caremark stock still trades above CVS bid and the slightly higher offer from rival suitor Express Scripts. The battle isn t over yet.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)